My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson's diseases, diabetes or blood diseases.

capable of generating all cell lineages of the body and were soon after capable of generating mice from iPS cells. Recognition
In 2007 Yamanaka was recognized as a "Person Who Mattered" in the Time Person of the Year edition of Time Magazine. After this he went through a residency in orthopedic surgery at National Osaka Hospital and a postdoctoral fellowship at the Gladstone Institute of Cardiovascular Disease San Francisco.

David Gladstone Institutes in San Francisco California; and as a professor of anatomy at University of California San Francisco (UCSF). He received the Wolf Prize in Medicine in 2011 with Rudolf Jaenisch; the Millennium Technology Prize in 2012 together with Linus Torvalds. He serves as the director of Center for iPS Cell Research and Application and a professor at the Institute for Frontier Medical Sciences at Kyoto University; as a senior investigator at the UCSF-affiliated J.